Cargando…
Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization
Monoacylglycerol O-acyltransferase 2 (MGAT2) catalyzes the synthesis of diacylglycerol (DG), a triacylglycerol precursor and potential peripheral target for novel anti-obesity therapeutics. High-throughput screening identified lead compounds with MGAT2 inhibitory activity. Through structural modific...
Autores principales: | Take, Kazumi, Mochida, Taisuke, Maki, Toshiyuki, Satomi, Yoshinori, Hirayama, Megumi, Nakakariya, Masanori, Amano, Nobuyuki, Adachi, Ryutaro, Sato, Kenjiro, Kitazaki, Tomoyuki, Takekawa, Shiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777574/ https://www.ncbi.nlm.nih.gov/pubmed/26938273 http://dx.doi.org/10.1371/journal.pone.0150976 |
Ejemplares similares
-
Inhibition of MGAT2 modulates fat‐induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high‐fat diet
por: Mochida, Taisuke, et al.
Publicado: (2020) -
Metabolic importance of adipose tissue monoacylglycerol acyltransferase 1 in mice and humans
por: Liss, Kim H. H., et al.
Publicado: (2018) -
Recruiting a New Substrate for Triacylglycerol Synthesis in Plants: The Monoacylglycerol Acyltransferase Pathway
por: Petrie, James R., et al.
Publicado: (2012) -
The monoacylglycerol acyltransferase pathway contributes to triacylglycerol synthesis in HepG2 cells
por: McFie, Pamela J., et al.
Publicado: (2022) -
Correction: Recruiting a New Substrate for Triacylglycerol Synthesis in Plants: The Monoacylglycerol Acyltransferase Pathway
por: Petrie, James R., et al.
Publicado: (2012)